Yaizu, Japan

Masanobu Munekata

This inventor holds 1 USPTO granted patent. Top assignee: Sapporo Breweries Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanobu Munekata. Retrieved from https://idiyas.com/inventor/masanobu-munekata-ky6i30jo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masanobu Munekata: Innovator in Immunology

Introduction

Masanobu Munekata is a notable inventor based in Yaizu, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on lymphokine activated killer suppressive factor (LAKSF). His research has implications for medical applications, especially in immunosuppression.

Latest Patents

Masanobu Munekata holds a patent for the "Lymphokine activated killer suppressive factor (LAKSF), process for." This patent details a process for producing LAKSF by cultivating human mono-cytic cells for alveolar macrophages activated by a stimulator to produce LAKSF and harvesting it. The LAKSF exhibits LAK induction suppressive activity and an immunosuppressive effect, making it useful as a medicine.

Career Highlights

Masanobu Munekata is associated with Sapporo Breweries Limited, where he applies his expertise in immunology. His work has garnered attention for its potential therapeutic applications, particularly in enhancing the understanding of immune responses.

Collaborations

Masanobu has collaborated with notable colleagues, including Saburo Sone and Akito Nakamura. These partnerships have contributed to the advancement of research in the field of immunology.

Conclusion

Masanobu Munekata's innovative work in developing LAKSF highlights his significant contributions to immunology. His research not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…